FDA May Approve Remdesivir After Positive Drug Trial Results

April 30, 2020
Dr. Fauci

© Sipa USA


The FDA will reportedly approve a new drug called remdesivir to treat coronavirus patients after receiving positive results from a study, CNN reports. The government agency is in talks with the drug maker Gilead Sicences, about possibly making it available to patients suffering from COVID-19, "as quickly as possible, as appropriate," FDA spokesman Michael Felberbaum said. The study found that patients who took the drug recovered faster than those who did not, with average recovery time of 11 days, down from 15. Dr. Anthony Fauci was optimistic about the study results. "The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery," Fauci said Wednesday. "Although a 31% improvement doesn't seem like a knockout 100%, it is very important proof of concept," Fauci said of remdesivir. "What it has proven is that a drug can block this virus. Results also suggested a survival benefit, with a mortality rate of 8.0% for the group receiving remdesivir versus 11.6% for the placebo group," the said.